SUPPORTING STATEMENT
1. Need
and Legal Basis
The
European Community (EC) is a group of 27 European countries that have
agreed to harmonize their commodity requirements to facilitate
commerce among member States. EC legislation for intra-EC trade has
been extended to trade with non-EC countries, including the United
States. For certain food products (e.g., shell eggs, dairy products,
game meat, game meat products, animal casings, and gelatin), EC
legislation requires assurances from the responsible authority of the
country of origin that the processor of the food is in compliance
with applicable regulatory requirements. FDA uses a list process to
meet this requirement. FDA requests information from processors that
export certain animal-derived products (e.g., shell eggs, dairy
products, game meat, game meat products, animal casings, and gelatin)
to the EC. FDA uses the information to maintain lists of processors
that have demonstrated current compliance with U.S. requirements and
provides the lists to the EC quarterly. Inclusion on the list is
voluntary. EC member countries refer to the lists at ports of entry
to verify that products offered for importation to the EC from the
United States are from processors that meet U.S. regulatory
requirements. Products processed by firms not on the lists are
subject to detention and possible refusal at the port.
Through this
process, FDA is implementing the general policy-making authority
granted the Commissioner under 21 U.S.C. 393(d)(2).
2. Information
Users
FDA requests the following information from each processor seeking to be included on the lists:
1. Business name and address;
2. Name and telephone number of person designated as business contact;
3. Lists of products presently being shipped to the EC and those intended to be shipped in the next 6 months;
4. Name and address of manufacturing plants for each product; and,
5. Names and affiliations of any Federal, State, or local governmental agencies that inspect the plant, government-assigned plant identifier such as plant number, and last date of inspection.
As noted above, FDA uses the information to maintain lists of processors that have demonstrated current compliance with U.S. requirements. FDA provides the lists to the EC quarterly and publishes the lists on the Internet at http://www.ams.usda.gov/dairy/eu_prgm.htm.
3. Improved
Information Technology
Through
the use of improved information technology the agency is always
seeking ways to reduce the burden of maintaining such lists. Firms
may submit the required information in electronic format.
4. Duplication
of Similar Information
There
is no duplication of effort in this area.
No other agency
collects this information. The Food Safety Inspection Service (FSIS)
and the Agricultural Marketing Service (AMS) of the U. S. Department
of Agriculture (USDA) perform some voluntary inspection and grading
of the commodities but maintains no lists of those companies that
export to the EC.
5. Small
Businesses
FDA
recognizes that some of the affected firms are small businesses, and
has kept their particular needs in mind throughout the development of
this list process. There is no known way to reduce the burden on a
small business wishing to participate in the list process. FDA
aids small businesses through the Division of Education and
Communication in the Center for Food Safety and Applied Nutrition
(CFSAN) and through the scientific and administrative staffs of the
agency.
6. Less
Frequent Collection
The
lists are required by the EC for specific commodities of animal
origin to enter into any of the EC member states. Less frequent
collection would not impact any federal program. The impact would be
on the U.S. exporters of dairy, shell eggs, animal casings, gelatin,
collagen and game meat and game meat products; their commodities
would be detained at the EC port of entry.
7. Special
Circumstances
The
list process does not involve submission of information to the agency
more than quarterly, written responses to the agency in less than 30
days, submission of more than two copies, retention of records for
more than three years, the use of statistical methods, pledges of
confidentiality by FDA, or require the disclosure of trade secrets or
other confidential information.
8. Federal
Register
Notice/Outside Consultation
In
accordance with 5 CFR 1320.8(d), on June 21, 2007 (72 FR 34256), a
60-day notice for public comment was published in the Federal
Register. No
comments were received from the public.
9. Payment/Gift
to Respondent
The
information collection does not provide for any gift or payment to
respondents.
10. Confidentiality
The
information to be collected is used in lists transmitted to the EC
and published on the Internet in order to facilitate trade. Thus,
there is no assurance of confidentiality of the information provided
by respondents.
11. Sensitive
Questions
The
information to be collected does not involve questions of a sensitive
nature.
12. Burden
Estimate (Total Hours and Wages)
FDA
estimates the burden of this collection of information as follows:
Table 1. -- Estimated Annual Reporting Burden1 |
|||||
Products |
No. of Respondents |
No. Of Responses per Respondent |
Total Annual Responses |
Hours per Response |
Total Hours |
Shell Eggs |
10 |
1 |
10 |
0.25 |
3 |
Dairy |
120 |
1 |
120 |
0.25 |
30 |
Game Meat and Meat Products |
5
|
1 |
5 |
0.25 |
1 |
Animal Casings |
5 |
1 |
5 |
0.25 |
1 |
Gelatin |
3 |
1 |
3 |
0.25 |
1 |
Collagen |
3 |
1 |
3 |
0.25 |
1 |
TOTAL |
37 |
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate on the responses received over the past three years. We estimate that the annual reporting burden would be approximately 37 hours. The time to respond to the questions should take approximately 15 minutes using any of the technologies available to transmit the information. All of the information asked for should be readily available. No record retention is required. In previous years, FDA estimated that the agency’s communication with trade associations and states resulted in a reporting burden of 520 hours. FDA no longer receives information from trade associations and states pursuant to this program. Accordingly, the proposed annual burden for this information collection has been reduced by 520 hours. Therefore, the proposed annual burden for this information collection is 37 hours.
Cost
to the Respondent
FDA estimates that there are 146 respondent firms. We estimate the average hourly wage of an employee responding to the information collection to be equivalent to that of a base GS-12, step 5 hourly wage ($30.57/hour per the 2007 GS Salary Table). Doubling this wage to account for overhead costs, FDA estimates the hourly cost to respondents to be $61.14. Thus, the estimated cost incurred by the respondents is $2,262 (37 burden hours x $61.14/hr = $2,262.18).
13. Capital
Costs (Maintenance of Capital Costs)
There
are no capital costs or operating and maintenance costs associated
with this collection of information.
14. Cost
to Federal Government
FDA
employees review the information collected and maintain the list
process. The 146 respondent firms submit one response each. We
estimate that each response will take two hours of time, or 292 hours
annually for all responses (146 x 2 = 292). We estimate the average
hourly wage of this Federal employee to be that of a base GS-13, step
5 ($36.36/hour per the 2007 GS Salary Table). Doubling this wage to
account for overhead costs, FDA estimates the hourly cost to the
Federal government to be $72.72. Thus, the estimated annual cost to
the Federal government is estimated to be $21,234 (292 hours x
$72.72/hr = $21,234.24).
15. Program
or Burden Changes
In
previous years, FDA estimated that the agency’s communication
with trade associations and states resulted in a reporting burden of
520 hours. FDA no longer receives information from trade
associations and states pursuant to this program. Accordingly,
the proposed annual burden for this information collection has been
reduced by 520 hours. In addition, FDA has increased the number of
dairy producers it estimates will seek to be on the list, from 100 to
120. Taking into account both the reduction in hours and the
increase, the collection has experienced an overall decrease in
burden.
16. Publication
and Tabulation Dates
FDA
publishes a copy of the list on the Internet.
17. Display
of OMB Approval Date
There
are no reasons why display of the expiration date for OMB approval of
the information collection would be inappropriate.
18. Exceptions
to “Certification for Paperwork Reduction Act Submissions”
No
exceptions to the certification statement identified in Item 19 of
the instructions for completing OMB Form 83-I have been identified.
File Type | application/msword |
File Title | Supporting Statement for |
Author | Joanna Capezzuto |
Last Modified By | Jonna Capezzuto |
File Modified | 2007-08-30 |
File Created | 2007-08-30 |